Literature DB >> 19132266

Nutritional status of patients with gynecologic and breast cancer.

R Zorlini1, A Akemi Abe Cairo, M Salete Costa Gurgel.   

Abstract

OBJECTIVE: To identify the preoperative nutritional status of women with gynecologic or breast cancer, in correlation with disease site and staging as well as previous treatments. SUBJECTS AND METHODS: A cross-sectional study of 250 women evaluated by Body Mass Index (BMI) and Subjective Global Assessment (SGA). For data analysis, the chi-square test was applied.
RESULTS: Breast cancer was the most frequent cancer, predominating in 56.2%. The median age of the patients was 52 years. In about 57% of these women, the tumor was restricted to clinical stages 0, I and II and 77% of the women had not undergone any other oncologic treatment prior to surgery. Subjective Global Assessment detected 76% of nourished women and 24% undernourished women, while Body Mass Index identified 34% of nourished women, 3.6% undernourished women and 62.4% overweight/obese women. A low level of diagnostic agreement between normal nutrition and malnutrition by both methods was observed (63.8%; kappa (95% CI) = 0.0884 (-0.07-0.24). No correlation between nutritional evaluation and previous treatment and disease staging was observed. Concerning anatomic site, it was subjectively observed that women with cancer of the uterine corpus were more malnourished than the rest (p = 0.02).
CONCLUSIONS: The findings suggest that a more careful evaluation should be employed to identify preoperative nutritional status in women with gynecologic or breast cancer.

Entities:  

Mesh:

Year:  2008        PMID: 19132266

Source DB:  PubMed          Journal:  Nutr Hosp        ISSN: 0212-1611            Impact factor:   1.057


  8 in total

1.  Body weight changes in patients undergoing chemotherapy for ovarian cancer influence progression-free and overall survival.

Authors:  Marcin Mardas; Marta Stelmach-Mardas; Radosław Madry
Journal:  Support Care Cancer       Date:  2016-10-22       Impact factor: 3.603

2.  Dietary habits changes and quality of life in patients undergoing chemotherapy for epithelial ovarian cancer.

Authors:  Marcin Mardas; Małgorzata Jamka; Radosław Mądry; Jarosław Walkowiak; Marietta Krótkopad; Marta Stelmach-Mardas
Journal:  Support Care Cancer       Date:  2014-10-02       Impact factor: 3.603

3.  Applicability of the direct parameters of bioelectrical impedance in assessing nutritional status and surgical complications of women with gynecological cancer.

Authors:  I C R Cardoso; M A Aredes; G V Chaves
Journal:  Eur J Clin Nutr       Date:  2017-08-09       Impact factor: 4.016

4.  Dietary intake variability in the cycle of cytotoxic chemotherapy.

Authors:  Marcin Mardas; Radosław Mądry; Marta Stelmach-Mardas
Journal:  Support Care Cancer       Date:  2016-01-06       Impact factor: 3.603

5.  Patient-Generated Subjective Global Assessment in relation to site, stage of the illness, reason for hospital admission, and mortality in patients with gynecological tumors.

Authors:  Camila Santos Rodrigues; Gabriela Villaça Chaves
Journal:  Support Care Cancer       Date:  2014-09-16       Impact factor: 3.603

6.  Comparison of the Index of Nutritional Quality in Breast Cancer Patients With Healthy Women.

Authors:  Mojgan Behrad Nasab; Maryam Afsharfar; Mina Ahmadzadeh; Farhad Vahid; Maryam Gholamalizadeh; Saheb Abbastorki; Sayed Hossein Davoodi; Nazanin Majidi; Mohammad Esmail Akbari; Saeid Doaei
Journal:  Front Nutr       Date:  2022-03-24

Review 7.  Perioperative nutrition interventions for women with ovarian cancer.

Authors:  Hazel A Billson; Cathrine Holland; Janet Curwell; Valerie L Davey; Laura Kinsey; Lianna J Lawton; Alison J Whitworth; Sorrel Burden
Journal:  Cochrane Database Syst Rev       Date:  2013-09-11

8.  Assessment of nutritional status of gynecological cancer cases in India and comparison of subjective and objective nutrition assessment parameters.

Authors:  Ushashree Das; Shilpa Patel; Kalpana Dave; Ronak Bhansali
Journal:  South Asian J Cancer       Date:  2014-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.